Clinical Trials Logo

Clinical Trial Summary

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Pterygium
  • Pterygium of Conjunctiva and Cornea

NCT number NCT03321201
Study type Interventional
Source University of Split, School of Medicine
Contact
Status Recruiting
Phase N/A
Start date May 8, 2018
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT03363282 - Recurrence Rate of Mini-SLET vs. Limbal-Conjunctival Autograft in Primary Pterygium Excision N/A
Withdrawn NCT03037736 - Outpatient Performed Pterygium Surgery Study Phase 4
Completed NCT03507283 - Vertical Split Conjunctival Autograft in Double-head Pterygia